QuickView for SCF;jsessionid=9574E8CA51F66DFBB5909E94F444F147;jsessionid=674A76569B3C49E056F350F417DD1ABA;jsessionid=B2264B0B024E2F3B11C6F965DEFB03E0;jsessionid=44ED9A4ACDC97C5FB2F4B5715FEEAF65 (gene)

1. Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recomb…
2. Creatine phosphate disodium salt protects against Dox-induced cardiotoxicity by increasing calumenin…
3. Protective effect of miR378* on doxorubicin-induced cardiomyocyte injury via calumenin.
4. CALU polymorphism A29809G affects calumenin availability involving vascular calcification.
5. Biophysical characterisation of calumenin as a charged F508del-CFTR folding modulator.

There were no clinical trials for SCF;jsessionid=9574E8CA51F66DFBB5909E94F444F147;jsessionid=674A76569B3C49E056F350F417DD1ABA;jsessionid=B2264B0B024E2F3B11C6F965DEFB03E0;jsessionid=44ED9A4ACDC97C5FB2F4B5715FEEAF65